Targeting of streptococci by zoocin A

FEMS Microbiology Letters

Volumn 270, Issue 1, 2007, Pages 155-161

  Akesson, Maria ^a   Dufour, Muriel ^a   Sloan, Gary L ^b   Simmonds, Robin S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF ALABAMA   (United States)

Author keywords

Cell binding; Endopeptidase; Peptidoglycan; Streptococcus; Zoocin A

Indexed keywords

CARBON 14; PEPTIDOGLYCAN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ZOOCIN A;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CELL SURFACE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG PURIFICATION; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STREPTOCOCCUS; STREPTOCOCCUS EQUI ZOOEPIDEMICUS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS RATTUS;

BACTERIAL PROTEINS; BACTERIOCINS; CARBON RADIOISOTOPES; MICROBIAL SENSITIVITY TESTS; PEPTIDOGLYCAN; PROTEIN BINDING; STREPTOCOCCUS; STREPTOCOCCUS EQUI; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS; STREPTOCOCCUS EQUI; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS RATTI;

EID: 34247156271     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2007.00669.x     Document Type: Article

References (33)

1. Beatson SA, Sloan GL & Simmonds RS (1998) Zoocin A immunity factor: a femA-like gene found in a Group C Streptococcus. FEMS Microbiol Lett 163: 73-77.
2. Bergstrom N, Jansson P-E, Kilian M & Skov Sorensen UB (2000) Structures of two cell wall-associated polysaccharides of a Streptococcus mitis biovar 1 strain: a unique teichoic acid-like polysaccharide and the group O antigen which is a C-polysaccharide in common with pneumococci. Eur J Biochem 267: 7147-7157.
3. Beukes M & Hastings JW (2001) Self-protection against cell wall hydrolysis in Streptococcus milleri NMSCC 061 and analysis of the Millericin B Operon. Appl Environ Microbiol 67: 3888-3896.
4. Beukes M, Bierbaum G, Sahl H-G & Hastings JW (2000) Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061. Appl Environ Microbiol 66: 23-28.
5. Bockelmann W, Hoppe-Seyler T & Heller KJ (1996) Purification and characterization of an endopeptidase from Lactobacillus delbrueckii subsp. Bulgaricus B14. Int Dairy J 6: 1167-1180.
6. Farris MH, Heath LS, Heath HE, LeBlanc PA, Simmonds RS & Sloan GL (2003) Expression of the genes for lysostaphin and lysostaphin resistance in streptococci. FEMS Microbiol Lett 228: 115-119.
7. Fischetti V (2003) Novel method to control pathogenic bacteria on human mucous membranes. Ann NY Acad Sci 987: 207-214.
8. Gopal PK & Reilly KI (1995) Molecular architecture of the lactococcal cell surface as it relates to important industrial properties. Int Dairy J 5: 1095-1111.
9. Grundling A & Schneewind O (2006) Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188: 2463-2472.
10. Heath LS, Heath HE, LeBlanc PA, Smithberg SR, Dufour M, Simmonds RS & Sloan GL (2004) The streptococcolytic enzyme zoocin A is a penicillin-binding protein. FEMS Microbiol Lett 236: 205-211.
11. Jado I, Lopez R, Garcia E, Fenoll A, Casal J & Garcia P (2003) Phage lytic enzymes as therapy of antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52: 967-973.
12. Lai AC-Y, Tran S & Simmonds RS (2002) Functional characterization of domain structures found within a lytic enzyme produced by Streptococcus equi subsp. Zooepidemicus. FEMS Microbiol Lett 215: 133-138.
13. Lopez R & Garcia E (2004) Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophages. FEMS Microbiol Rev 28: 553-580.
14. Markam JL, Knox KW, Wicken AJ & Hewett MJ (1975) Formation of extracellular lipoteichoic acid by oral streptococci and lactobacilli. Infect Immun 12: 378-386.
15. Navaree WW & Schneewind O (1999) Surface proteins of grampositive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63: 174-229.
16. Nelson D, Loomis L & Fischetti VA (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98: 1917-1924.
17. Niamke S, Sine J-P, Guionie O & Colas B (1999) A novel endopeptidase with a strict specificity for threonine residues at the P10 position. Biochem Biophys Res Commun 256: 307-312.
18. Ota F, Minato Y, Senesi S et al. (1989) Type-specific antigen of Streptococcus rattus strains (KAY1, FA1 and BHT) II. Ultrastructural localization. Int J Med Microbiol 271: 137-145.
19. Pritchard DG & Rener BP (1991) Structure of the type-specific polysaccharide antigen of Streptococcus rattus. Carbohydr Res 210: 247-254.
20. Schleifer KH & Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407-477.
21. Shockman GD & Barrett JF (1983) Structure, function and assembly of cell walls of gram-positive bacteria. Ann Rev Microbiol 37: 501-527.
22. Sieprawska-Lupa M, Mydel P, Krawczyk K et al. (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48: 4673-4679.
23. Simmonds RS, Naidoo J, Jones CL &Tagg JR (1995) The streptococcal bacteriocin-like inhibitory susbstance, zoocin A, reduces the proportion of Streptococcus mutans in an artificial plaque. Microb Ecol Health Dis 8: 281-292.
24. Simmonds RS, Pearson L, Kennedy RC & Tagg JR (1996)Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus strain 4881. Appl Environ Microbiol 62: 4536-4541.
25. Simmonds RS, Simpson WJ & Tagg JR (1997) Cloning and sequence analysis of zooA, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin. Gene 189: 255-261.
26. Steen A, Buist G, Leenhouts KJ et al. (2003) Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents. J Biol Chem 278: 23874-23881.
27. Szweda P, Kotlowski R & Kur J (2005) New effective sources of the Staphylococcus simulans lysostaphin. J Biotechnol 117: 203-213.
28. Timoney FF (2004) The pathogenic equine streptococci. Vet Res 35: 397-409.
29. Wall RJ, Powell AM, Paape MJ et al. (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23: 445-451.
30. Walsh S, Kokai-Kun JF, Shah A & Mond JJ (2004) Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers. Pharma Res 21: 1770-1775.
31. Wu JA, Kusuma C, Mond JJ & Kokai-Kun JF (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47: 3407-3414.
32. Wilkinson BJ, Muthaiyan A & Jayaswal RK (2005) The cell wall stress stimulon of Staphylococcus aureus and other grampositive bacteria. Curr Med Chem Anti-Inf Agents 4: 259-276.
33. Zhiqiang Lu J, Fujiwara T, Komatsuzawa H, Sugai M & Sakon J (2006) Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan crossbridges. J Biol Chem 281: 549-558.